Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 432
Selected: 0
NCT IDTitle
NCT01300962Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
NCT03672396Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer
NCT02191982The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
NCT07826780The STRONG Nutrition Support Study for People With Pancreatic Cancer
NCT04644419Chemotherapy-related Cognitive Impairment and Acute Leukemia
NCT03769415Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
NCT04548648A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas
NCT00767468Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
NCT05011890Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
NCT01173497A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
NCT02075320Evaluation of the Lung Nodule Sensitivity of Stationary Chest Tomosynthesis in Patients With Known Lung Nodules
NCT02003417Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy
NCT03820024MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
NCT04974489Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
NCT06860880Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
NCT02306252The CARE Program: CAncer REhabilitation Pilot Study for Older Adults
NCT04564989Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
NCT07829146Feasibility Pilot of AYA-PARTNER
NCT04920188Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
NCT03594162Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
NCT07294066Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
NCT01665703Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT04535141Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants
NCT01956253Single Subject Neratinib in Bladder Cancer (NRR)
NCT05440929Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
NCT0548302318-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
NCT02781025Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
NCT03862105Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer
NCT01148875Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer
NCT03156244Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients
NCT03595878Trial of Parotid Sparing Whole Brain Radiation
NCT07084168Multimedia Aid for Genetic Testing in Gynecologic Oncology
NCT06347068Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
NCT05592665PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
NCT05722847Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer
NCT03076333PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT02564458Fitness in Allogeneic Stem Cell Transplantation
NCT00005827Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
NCT00283244Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
NCT03160209HIV and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Malawi
NCT06171945Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors
NCT07068477Adaptation of a Values Assessment Tool
NCT04223765Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
NCT00232505Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
NCT02609503Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
NCT07061652Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
NCT01845519Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors
NCT01759355Hybrid PET/MR in the Therapy of Cervical Cancer
NCT01164215Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy
NCT04978350Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study